Health disparities and access to advanced therapy for overactive bladder
Sign Up to like & getrecommendations! Published in 2022 at "Neurourology and Urodynamics"
DOI: 10.1002/nau.24949
Abstract: Refractory overactive bladder (OAB) is among the most common reasons for referral to specialists in voiding dysfunction. Significant racial and ethnic disparities exist in prevalence, severity, and management of OAB, presenting care barriers for marginalized… read more here.
Keywords: bladder; access advanced; advanced therapy; disparities access ... See more keywords
Managing access to advanced therapy medicinal products: Challenges for NHS Wales
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.14286
Abstract: Advanced Therapy Medicinal Products (ATMPs), which include gene, somatic cell therapies and tissueâengineered medicines, have the potential to transform current care pathways by offering durable and potentially curative outcomes. However, they are exceptionally expensive, with… read more here.
Keywords: therapy medicinal; access advanced; medicinal products; advanced therapy ... See more keywords